Loulou Foundation announces First-Patient-In for CANDID observational study on CDKL5 Deficiency DisorderBusiness Wire • 10/31/22
Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MSGlobeNewsWire • 10/26/22
New Data at ECTRIMS 2022 Highlight Biogen's Commitment to Advancing Individualized Disease Management for People Living with MSGlobeNewsWire • 10/26/22
Biogen Inches Higher On Third-Quarter Beat, But All Eyes Watch Alzheimer's DrugInvestors Business Daily • 10/25/22